Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 04, 2021

SELL
$9.9 - $11.56 $162,468 - $189,711
-16,411 Closed
0 $0
Q1 2021

Apr 23, 2021

SELL
$10.34 - $12.81 $140,013 - $173,460
-13,541 Reduced 45.21%
16,411 $189,000
Q4 2020

Jan 22, 2021

BUY
$8.61 - $11.04 $12,054 - $15,455
1,400 Added 4.9%
29,952 $289,000
Q3 2020

Oct 16, 2020

SELL
$8.57 - $12.69 $1,251 - $1,852
-146 Reduced 0.51%
28,552 $257,000
Q2 2020

Jul 21, 2020

BUY
$8.12 - $13.12 $10,182 - $16,452
1,254 Added 4.57%
28,698 $354,000
Q1 2020

Apr 16, 2020

BUY
$6.69 - $13.45 $18,932 - $38,063
2,830 Added 11.5%
27,444 $246,000
Q4 2019

Jan 23, 2020

BUY
$6.53 - $10.72 $11,101 - $18,224
1,700 Added 7.42%
24,614 $241,000
Q3 2019

Oct 15, 2019

SELL
$6.16 - $9.6 $10,472 - $16,320
-1,700 Reduced 6.91%
22,914 $158,000
Q2 2019

Jul 18, 2019

SELL
$8.12 - $15.72 $16,361 - $31,675
-2,015 Reduced 7.57%
24,614 $227,000
Q1 2019

Apr 17, 2019

SELL
$15.58 - $20.01 $53,813 - $69,114
-3,454 Reduced 11.48%
26,629 $418,000
Q4 2018

Jan 30, 2019

BUY
$14.59 - $23.84 $13,349 - $21,813
915 Added 3.14%
30,083 $464,000
Q3 2018

Oct 09, 2018

SELL
$21.06 - $25.65 $18,427 - $22,443
-875 Reduced 2.91%
29,168 $628,000
Q2 2018

Jul 16, 2018

SELL
$16.77 - $24.71 $7,965 - $11,737
-475 Reduced 1.56%
30,043 $731,000
Q1 2018

Apr 16, 2018

SELL
$16.68 - $22.07 $27,722 - $36,680
-1,662 Reduced 5.16%
30,518 $522,000
Q4 2017

Feb 07, 2018

BUY
$11.23 - $19.1 $95,275 - $162,044
8,484 Added 35.8%
32,180 $610,000
Q3 2017

Nov 01, 2017

BUY
$15.41 - $32.17 $365,155 - $762,300
23,696
23,696 $417,000

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19.4B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Nwam LLC Portfolio

Follow Nwam LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nwam LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nwam LLC with notifications on news.